Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Boehringer Ingelheim
Chinese Patent Office
Deloitte
Farmers Insurance
Merck
Federal Trade Commission
Healthtrust
Cerilliant

Generated: April 24, 2018

DrugPatentWatch Database Preview

CITANEST PLAIN Drug Profile

« Back to Dashboard

Which patents cover Citanest Plain, and what generic alternatives are available?

Citanest Plain is a drug marketed by Astrazeneca and Dentsply Pharm and is included in two NDAs.

The generic ingredient in CITANEST PLAIN is prilocaine hydrochloride. There are seven drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the prilocaine hydrochloride profile page.
Drug patent expirations by year for CITANEST PLAIN
Medical Subject Heading (MeSH) Categories for CITANEST PLAIN
Synonyms for CITANEST PLAIN
1786-81-8
2-(Propylamino)-
2-(Propylamino)-m-propionotoluidide Hydrochloride
2-(Propylamino)-N-(o-tolyl)propanamide hydrochloride
2-(Propylamino)-N-(o-tolyl)propionamide Hydrochloride
2-(Propylamino)-o-propionotoluidide hydrochloride
2-(Propylamino)-o-propionotoluidide hydrochloride; N-(2-Methylphenyl)-2-(propylamino)-propanamide hydrochloride
2-(Propylamino)-o-propionotoluidide monohydrochloride
786P818
878791-35-6
A812391
AB0005494
AB1004860
AC-2099
AC1L3NJV
ACT04757
AK161938
AKOS015895106
alpha-Propylamine-2-methyl-propionanilide hydrochloride
AN-14287
API0003927
ARONIS24439
AX8040365
BBC/603
BC209185
BCP0726000006
BG0296
CAS-1786-81-8
CCG-39327
CHEBI:32053
CHEMBL1200586
Citanest (TN)
Citanest hydrochloride
CPD000058506
CS-1930
CTK8G2574
D01243
DSSTox_CID_11956
DSSTox_GSID_31956
DSSTox_RID_78897
DT1296
DTXSID2031956
EBD2408
EINECS 217-244-0
EN300-188472
EU-0101005
FC1266
FT-0633840
GP0348
HE222438
HMS1568H19
HMS1922O15
HY-B0137A
I06-0422
J10292
KS-5024
L 67 Hydrochloride
L-67
LP01005
LS-119349
LS-119350
LS-119351
LS-2121
M-1534
MCULE-7993425453
MFCD00079279
MLS000069690
MLS002222230
MLS002548864
MolPort-003-666-478
N-(2-Methylphenyl)-2-(propylamino)-propanamide hydrochloride
N-(2-Methylphenyl)-2-(propylamino)propanamide hydrochloride
N-(2-methylphenyl)-2-(propylamino)propanamide, chloride
N-(2-methylphenyl)-2-(propylamino)propanamide;hydrochloride
N-(2-methylphenyl)-N2-propylalaninamide hydrochloride
N-(3-Methylphenyl)-2-(propylamino)propanamide Hydrochloride
N-(o-tolyl)-2-(propylamino)propanamide hydrochloride
NC00474
NCGC00015860-06
NCGC00016594-01
NCGC00094299-01
NCGC00094299-02
NCGC00094299-03
NCGC00094299-04
NCGC00094299-05
NCGC00261690-01
NSC-758432
NSC758432
o-Propionotoluidide, 2-(propylamino)-, monohydrochloride
Opera_ID_480
P 9547
P2038
Pharmakon1600-01503270
Prestwick_616
Prilocaine (hydrochloride)
Prilocaine chloride
Prilocaine for peak identification, European Pharmacopoeia (EP) Reference Standard
Prilocaine HCl
Prilocaine hydrochloride
PRILOCAINE HYDROCHLORIDE (PRILOCAINE (721-50-6))
Prilocaine hydrochloride (USP)
Prilocaine hydrochloride [USAN:USP]
Prilocaine hydrochloride [USAN]
Prilocaine hydrochloride, >=98% (TLC)
Prilocaine hydrochloride, European Pharmacopoeia (EP) Reference Standard
Prilocaine hydrochloride, meets USP testing specifications
Prilocaine hydrochloride, United States Pharmacopeia (USP) Reference Standard
Propanamide, N-(2-methylphenyl)-2-(propylamino)-, monohydrochloride
Propitocaine HCl
Propitocaine hydrochloride
Propitocaine hydrochloride (JAN)
Propitocainehydrochloride
Q-201619
SAM002264640
SC-22683
SCHEMBL330180
SMR000058506
SPECTRUM1503270
SR-01000076094
SR-01000076094-1
ST24049036
ST51015112
Tox21_110513
Tox21_110513_1
Tox21_501005
Xylonest
ZX-AS004804

US Patents and Regulatory Information for CITANEST PLAIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Astrazeneca CITANEST PLAIN prilocaine hydrochloride INJECTABLE;INJECTION 014763-007 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Dentsply Pharm CITANEST PLAIN DENTAL prilocaine hydrochloride INJECTABLE;INJECTION 021382-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Johnson and Johnson
Julphar
Farmers Insurance
US Army
Healthtrust
Federal Trade Commission
Moodys
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.